Repeat ablative therapy in hereditary or multifocal renal cancer: Functional and oncological outcomes.

Date publication

août 2020

Journal

Urologic oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GANGI Afshin , Pr LANG Hervé , Dr GARNON Julien , Dr TRICARD Thibault , Dr CAZZATO Roberto-Luigi

Tous les auteurs :
Gaillard V, Tricard T, Garnon J, Cazzato RL, Dalili D, Gangi A, Lang H

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32778477

Résumé

To report managing renal tumors in patients at greater risk of repeated interventions (genetic predisposition, multifocal tumors) with thermoablative treatments (AT). A known significant challenge in these patients is the balance between nephron preservation and oncologic outcome.

Mots clés

Ablative therapies, Cryotherapy, Hereditary renal cancer

Référence

Urol. Oncol.. 2020 Aug 7;: